In addition to increasing apoptosis, our results showing that JQ1 can reduce the hypersecretion of ACTH may also provide a possible treatment for Cushing’s syndrome, which is one of the key morbidities of corticotrophinomas (Ntali et al. 2013). Here, POMC is linked to Cushing syndrome due to macronodular adrenal hyperplasia.